A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2011
10/26/2011	EP2379534A1 Heterocyclic antiviral compounds
10/26/2011	EP2379520A2 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
10/26/2011	EP2379499A1 New salts
10/26/2011	EP2379498A1 New polymorphic form of 1- (4- { l- ý (e) -4-cyclohexyl--3-trifluoromethyl-benzyloxyimino¨-ethyl) -2-ethyl-benzy l) -azetidine-3-carboxylic
10/26/2011	EP2379105A1 Vaccine
10/26/2011	EP2379103A1 Immunogenic composition and use thereof
10/26/2011	EP2379079A1 Pharmaceutical formulations comprising voriconazole and processes for preparation thereof
10/26/2011	EP2181985B1 Antiviral Agent
10/26/2011	EP2120590B1 Use of lactobacillus casei for increasing the protection provided by the influenza vaccine
10/26/2011	EP2022786B1 Anti-foot-and-mouth disease virus agent for animal belonging to family suidae or sheep, and method for prevention or treatment of foot-and-mouth disease in animal belonging to family suidae or sheep
10/26/2011	EP1871395B1 Garlic extract and chitosan compositions, and uses thereof
10/26/2011	EP1802650B1 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis c infection
10/26/2011	EP1742964B1 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation
10/26/2011	EP0787191B2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
10/26/2011	CN1868503B Preparation method of extractive of Herba Rabdosiae diterpene
10/26/2011	CN1762967B Enoxolone derivative, preparation method and uses
10/26/2011	CN102227442A Cytotoxic t cell epitope peptide for sars coronavirus, and use thereof
10/26/2011	CN102227436A Macrocyclic compounds as hepatitis c virus inhibitors
10/26/2011	CN102227435A Hepatitis c virus inhibitors
10/26/2011	CN102227411A Antibacterial compounds
10/26/2011	CN102227407A Hepatitis c virus inhibitors
10/26/2011	CN102227237A Host cell kinases as targets for antiviral therapies against hcv infection
10/26/2011	CN102226203A Construction and application of dual shRNA expression plasmid of dual chU6 promoter
10/26/2011	CN102226157A Lactobacillus fermentum and application thereof
10/26/2011	CN102225923A Method for preparing dihydromyricetin from Ampelopsis grossedentata
10/26/2011	CN102225902A Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
10/26/2011	CN102225194A Use of Bv8 and/or EG-VEGF to promote hematopoiesis
10/26/2011	CN102225185A Traditional Chinese medicine composition for treating condyloma acuminatum and preparation method thereof
10/26/2011	CN102225184A Traditional Chinese medicine composition for treating chicken colibacillosis
10/26/2011	CN102225156A Plaster for external use for treating dermatophytosis
10/26/2011	CN102225152A Preparation method of Maiwei rehmannia oral preparation
10/26/2011	CN102225146A Formula and production technology of traditional Chinese medicine injection for controlling bird flu
10/26/2011	CN102225131A Traditional Chinese medicine for resisting viruses
10/26/2011	CN102225114A Medicine for treating foot ringworm and preparation method thereof
10/26/2011	CN102225103A Formulation and production process of traditional Chinese medicinal injection solution for controlling Newcastle disease
10/26/2011	CN102225091A Method for preparing barbat skullcap total polyphenol
10/26/2011	CN102225080A Method for extracting flavonoid compounds from passion fruit leaves by ethanol-microwave soaking leaching process
10/26/2011	CN102225077A Application of Chinese gall extract for controlling streptococcal disease in aquaculture animals
10/26/2011	CN102225071A Preparation method of external medicine for treating tinea manuum and tinea pedis
10/26/2011	CN102225069A Drug composition causing low drug resistance, and its preparation method and application
10/26/2011	CN102225065A Parcetamol pseudoephedrine hydrochloride and dextromethorphan hydrochloride capsule and preparation method thereof
10/26/2011	CN102225062A Pharmaceutical composition for treating infectious diseases caused by Acinetobacter baumannii
10/26/2011	CN102225060A Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type 1 and type 2 cytokine production
10/26/2011	CN102225058A Oseltamivir phosphate dry powder inhalations and preparation method thereof
10/26/2011	CN102224975A Soaking liquid medicine for treating tinea manus and pedis and medical healthcare product
10/26/2011	CN101926900B Pediluvium composition and preparing method thereof
10/26/2011	CN101912483B Traditional Chinese medicine embrocation of children infantile eczema
10/26/2011	CN101897751B Application of pharynx-clearing dropping pills in preparing antiviral drugs
10/26/2011	CN101890016B Piperacillin sodium-tazobactam sodium medicinal composition microsphere injection
10/26/2011	CN101884654B Process for preparing bupleurum chinense injection
10/26/2011	CN101874874B Chinese medicinal preparation for treating helicobacter pylori concerned chronic gastritis and preparation method thereof
10/26/2011	CN101874777B Spray containing butenafine hydrochloride
10/26/2011	CN101816694B Echinacea purpurea oral liquid and preparation method and application thereof
10/26/2011	CN101671344B Eriosema chinense flavonoid extract and extracting method and application thereof
10/26/2011	CN101643477B Synthesis method of cefradine
10/26/2011	CN101618172B Traditional Chinese medicine for treating hepatitis B, cirrhosis, liver cancer and liver ascites
10/26/2011	CN101606992B Compound traditional Chinese medicine perfusion liquor for preventing and treating endometritis of dairy cow and preparation method thereof
10/26/2011	CN101596246B Smoked plum extractive and wild jujube seed extractive compound preparation as well as preparation method and application thereof
10/26/2011	CN101596230B Medicinal composition for treating hepatopathy
10/26/2011	CN101475943B Rabies viruses CTN strain complete genome infectious cDNA cloning, and preparation and use thereof
10/26/2011	CN101415705B Compounds and methods for inhibiting hepatitis c viral replication
10/26/2011	CN101310702B Emulsion type gel preparation containing chlorhexidine and alcohol
10/26/2011	CN101293003B Effect section of frangrant ainsliaea herb, preparation method and application thereof
10/26/2011	CN101070304B Quinoline derivatives and their use as mycrobacterial inhibitors
10/26/2011	CN101063112B Nucleoside diphosphokinase A oxidation-reduction isomer
10/26/2011	CN101048169B Graptopetalum and pharmaceutical use of related plants
10/25/2011	US8044195 Cross-linked glycopeptide-cephalosporin antibiotics
10/25/2011	US8044182 Adiponectin and uses thereof
10/25/2011	US8044102 administering to animals antibiotic deriavtives such as florfenicol or flunixin meglumine, for prevention of urogenital, respiratory system and gastrointestinal disorders, vision defects and mastitis; veterinary medicine
10/25/2011	US8044078 Amino-alkyl amide derivatives as CCR3 receptor ligands
10/25/2011	US8044040 e.g. 3-{3-Cyano-6-[(2,2-dimethyl-propyl)-methyl-amino]-5-fluoro-pyridin-2-ylamino}-N-methoxy-4-methyl-benzamide; via p38 kinase inhibition; (anilino)(halo)pyrimidine or (anilino)(amino)pyrimidine derivatives; rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis
10/25/2011	US8044031 Method for increasing the survival of aquatic and other animals exposed to an aquatic virus, birnavirus or other RNA virus and composition for such methods
10/25/2011	US8043624 Compositions and methods for treatment of microbial infections
10/25/2011	CA2657355C Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof
10/25/2011	CA2484020C Re-epithelializing pharmaceutical compositions comprising xanthan gum
10/25/2011	CA2437983C Transporters comprising spaced arginine moieties
10/25/2011	CA2372709C Vector for integration of heterologous sequences into poxviral genomes
10/25/2011	CA2341601C Use of selenium for treating patients suffering from systemic inflammatory response syndrome (sirs), and composition for implementing said treatment
10/25/2011	CA2341568C Stabilized pharmaceutical composition in lyophilized form
10/20/2011	WO2011130650A2 Antibodies for the treatment of clostridium difficile-associated infection and disease
10/20/2011	WO2011130557A2 Phosphonates with reduced toxicity for treatment of viral infections
10/20/2011	WO2011130419A2 Broad spectrum antiviral and antiparasitic agents
10/20/2011	WO2011130379A1 Benzonapthyridine compositions and uses thereof
10/20/2011	WO2011130301A2 Method of diagnosing and treating melioidosis
10/20/2011	WO2011129424A1 Pharmaceutical agent for prevention and/or treatment of htlv-1-associated myelopathy
10/20/2011	WO2011129120A1 Methods and compositions for intranasal delivery
10/20/2011	WO2011129095A1 Pyridone derivative having integrase inhibitory activity
10/20/2011	WO2011128905A1 Novel nutraceutical formulation isolated from the plants of family scrophulariaceae as anticancer, antiviral, antiaging and immunostimulating agent
10/20/2011	WO2011128445A1 Inhibitors of the accumulation of sprd transcripts in s. aureus
10/20/2011	WO2011128415A1 Cross-protecting vaccine for porcine reproductive and respiratory syndrome virus
10/20/2011	WO2011128378A1 Combination of a macrocyclic inhibitor of hcv, a non-nucleoside and a nucleoside
10/20/2011	WO2011127833A1 Benzoheterocyclic compounds, preparation methods and uses thereof
10/20/2011	WO2011127625A1 Method for regulating microrna content in organisms and uses thereof
10/20/2011	WO2011127624A1 Anti-hiv peptide
10/20/2011	WO2011127538A1 Compound for treatment of respiratory condition or disease
10/20/2011	WO2011095772A3 Novel iminosugar therapeutics
10/20/2011	WO2011093932A3 Design of fibrinogen and fibrinogen derived products with reduced bacterial binding by using modified sequences of fibrinogen chains
10/20/2011	WO2011084882A3 Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
10/20/2011	WO2011080739A3 Synergistic antibiotic combinations and derivatives
10/20/2011	WO2011063263A3 Methods for producing an immune response to tuberculosis

1 ... 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 ... 1798